NCT00090870 PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer Status TERMINATED Phase PHASE2
NCT00089219 Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT00076037 Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP Status COMPLETED Phase PHASE1
NCT00005780 Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00001564 A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas Status COMPLETED Phase PHASE2
NCT00001561 Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation Status COMPLETED Phase PHASE3
NCT00001512 Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines Status COMPLETED Phase PHASE1